TrialThe American journal of tropical medicine and hygiene2013

Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil.

Gustavo H Dayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.